Mutations in UBA3 Confer Resistance to the NEDD8-Activating Enzyme Inhibitor MLN4924 in Human Leukemic Cells

G. Wei Xu(University Health Network), Aaron D. Schimmer(University of Toronto)

PLoS ONE

April 1, 2014

10.1371/journal.pone.0093530

Cited by 43

Related Papers

A 17-gene stemness score for rapid determination of risk in acute leukaemia

|Nature|2016|916

Inhibition of Mitochondrial Translation as a Therapeutic Strategy for Human Acute Myeloid Leukemia

|Cancer Cell|2011|692

Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia

|Cancer Cell|2015|348

Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells

|Blood|2009|185

The ubiquitin-activating enzyme E1 as a therapeutic target for the treatment of leukemia and multiple myeloma

|Blood|2010|168